Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC3102C vs GC FLU inj. in Healthy Adults
NCT01750814Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Jun 2013
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of GC3102C in influenza (2 arms), sponsored by GC Biopharma. Primary endpoint: Geometric Mean Titer at Day 21. Started Jun 2013; status: completed.
02
Drugs
GC3102C
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01750814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750814.